Covid-19 Impact on Disease Control and Prevention Vaccine Market, Global Research Reports 2020-2021

2 Global Disease Control and Prevention Vaccine Quarterly Market Size Analysis

• 2.1 Disease Control and Prevention Vaccine Business Impact Assessment - COVID-19
  • 2.1.1 Global Disease Control and Prevention Vaccine Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
  • 2.1.2 Global Disease Control and Prevention Vaccine Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
• 2.2 Global Disease Control and Prevention Vaccine Quarterly Market Size 2020-2021
• 2.3 COVID-19-Driven Market Dynamics and Factor Analysis
  • 2.3.1 Drivers
  • 2.3.2 Restraints
  • 2.3.3 Opportunities
  • 2.3.4 Challenges

3 Quarterly Competitive Assessment, 2020

• 3.1 Global Disease Control and Prevention Vaccine Quarterly Market Size by Manufacturers, 2019 VS 2020
• 3.2 Global Disease Control and Prevention Vaccine Factory Price by Manufacturers
• 3.3 Location of Key Manufacturers Disease Control and Prevention Vaccine Manufacturing Factories and Area Served
• 3.4 Date of Key Manufacturers Enter into Disease Control and Prevention Vaccine Market
• 3.5 Key Manufacturers Disease Control and Prevention Vaccine Product Offered
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Impact of Covid-19 on Disease Control and Prevention Vaccine Segments, By Type

• 4.1 Introduction
  • 1.4.1 Live-Attenuated
  • 1.4.2 Inactivated
  • 1.4.3 Recombinant Sub Unit and Toxoid
• 4.2 By Type, Global Disease Control and Prevention Vaccine Market Size, 2019-2021
  • 4.2.1 By Type, Global Disease Control and Prevention Vaccine Market Size by Type, 2020-2021
  • 4.2.2 By Type, Global Disease Control and Prevention Vaccine Price, 2020-2021

5 Impact of Covid-19 on Disease Control and Prevention Vaccine Segments, By Application

• 5.1 Overview
  • 5.5.1 Pediatric Vaccine
  • 5.5.2 Adult Vaccine
• 5.2 By Application, Global Disease Control and Prevention Vaccine Market Size, 2019-2021
  • 5.2.1 By Application, Global Disease Control and Prevention Vaccine Market Size by Application, 2019-2021
  • 5.2.2 By Application, Global Disease Control and Prevention Vaccine Price, 2020-2021

6 Geographic Analysis

• 6.1 Introduction
• 6.2 North America
  • 6.2.1 Macroeconomic Indicators of US
  • 6.2.2 US
  • 6.2.3 Canada
• 6.3 Europe
  • 6.3.1 Macroeconomic Indicators of Europe
  • 6.3.2 Germany
  • 6.3.3 France
  • 6.3.4 UK
  • 6.3.5 Italy
• 6.4 Asia-Pacific
  • 6.4.1 Macroeconomic Indicators of Asia-Pacific
  • 6.4.2 China
  • 6.4.3 Japan
  • 6.4.4 South Korea
  • 6.4.5 India
  • 6.4.6 ASEAN
• 6.5 Rest of World
  • 6.5.1 Latin America
  • 6.5.2 Middle East and Africa

7 Company Profiles

• 7.1 GSK
  • 7.1.1 GSK Business Overview
  • 7.1.2 GSK Disease Control and Prevention Vaccine Quarterly Production and Revenue, 2020
  • 7.1.3 GSK Disease Control and Prevention Vaccine Product Introduction
  • 7.1.4 GSK Response to COVID-19 and Related Developments
• 7.2 Merck & Co., Inc
  • 7.2.1 Merck & Co., Inc Business Overview
  • 7.2.2 Merck & Co., Inc Disease Control and Prevention Vaccine Quarterly Production and Revenue, 2020
  • 7.2.3 Merck & Co., Inc Disease Control and Prevention Vaccine Product Introduction
  • 7.2.4 Merck & Co., Inc Response to COVID-19 and Related Developments
• 7.3 Pfizer
  • 7.3.1 Pfizer Business Overview
  • 7.3.2 Pfizer Disease Control and Prevention Vaccine Quarterly Production and Revenue, 2020
  • 7.3.3 Pfizer Disease Control and Prevention Vaccine Product Introduction
  • 7.3.4 Pfizer Response to COVID-19 and Related Developments
• 7.4 Sanofi
  • 7.4.1 Sanofi Business Overview
  • 7.4.2 Sanofi Disease Control and Prevention Vaccine Quarterly Production and Revenue, 2020
  • 7.4.3 Sanofi Disease Control and Prevention Vaccine Product Introduction
  • 7.4.4 Sanofi Response to COVID-19 and Related Developments
• 7.5 AstraZeneca PLC
  • 7.5.1 AstraZeneca PLC Business Overview
  • 7.5.2 AstraZeneca PLC Disease Control and Prevention Vaccine Quarterly Production and Revenue, 2020
  • 7.5.3 AstraZeneca PLC Disease Control and Prevention Vaccine Product Introduction
  • 7.5.4 AstraZeneca PLC Response to COVID-19 and Related Developments
• 7.6 Sinovac Biotech Ltd
  • 7.6.1 Sinovac Biotech Ltd Business Overview
  • 7.6.2 Sinovac Biotech Ltd Disease Control and Prevention Vaccine Quarterly Production and Revenue, 2020
  • 7.6.3 Sinovac Biotech Ltd Disease Control and Prevention Vaccine Product Introduction
  • 7.6.4 Sinovac Biotech Ltd Response to COVID-19 and Related Developments
• 7.7 Astellas Pharma Inc
  • 7.7.1 Astellas Pharma Inc Business Overview
  • 7.7.2 Astellas Pharma Inc Disease Control and Prevention Vaccine Quarterly Production and Revenue, 2020
  • 7.7.3 Astellas Pharma Inc Disease Control and Prevention Vaccine Product Introduction
  • 7.7.4 Astellas Pharma Inc Response to COVID-19 and Related Developments
• 7.8 Serum Institute of India Pvt. Ltd
  • 7.8.1 Serum Institute of India Pvt. Ltd Business Overview
  • 7.8.2 Serum Institute of India Pvt. Ltd Disease Control and Prevention Vaccine Quarterly Production and Revenue, 2020
  • 7.8.3 Serum Institute of India Pvt. Ltd Disease Control and Prevention Vaccine Product Introduction
  • 7.8.4 Serum Institute of India Pvt. Ltd Response to COVID-19 and Related Developments
• 7.9 Daiichi Sankyo
  • 7.9.1 Daiichi Sankyo Business Overview
  • 7.9.2 Daiichi Sankyo Disease Control and Prevention Vaccine Quarterly Production and Revenue, 2020
  • 7.9.3 Daiichi Sankyo Disease Control and Prevention Vaccine Product Introduction
  • 7.9.4 Daiichi Sankyo Response to COVID-19 and Related Developments

8 Supply Chain and Sales Channels Analysis

• 8.1 Disease Control and Prevention Vaccine Supply Chain Analysis
  • 8.1.1 Disease Control and Prevention Vaccine Supply Chain Analysis
  • 8.1.2 Covid-19 Impact on Disease Control and Prevention Vaccine Supply Chain
• 8.2 Distribution Channels Analysis
  • 8.2.1 Disease Control and Prevention Vaccine Distribution Channels
  • 8.2.2 Covid-19 Impact on Disease Control and Prevention Vaccine Distribution Channels
  • 8.2.3 Disease Control and Prevention Vaccine Distributors
• 8.3 Disease Control and Prevention Vaccine Customers

9 Key Findings

10 Appendix

• 10.1 About Us